Delaware Chancery Court Upholds Adoption And Use Of Poison Pill Triggered By Competitor’s Acquisition Of Stock


RE: Selectica, Inc. v. Versata Enterprises, Inc. (C.A. No. 4241-VCN)

On February 26, 2010, the Delaware Court of Chancery issued a post-trial opinion upholding the adoption and use of a poison pill aimed at preserving net operating losses (NOLs)1 of Selectica. This decision updates the guidance and analysis set forth in Moran v. Household Int’l.2 and Unocal Corp. v. Mesa Petroleum Co.3 concerning the adoption and use of defensive measures generally, and in particular the use of poison pills.

While the court stressed the fact-specific limits of its holding, the decision is important for a number of reasons, including that this is the first opinion issued by a Delaware court upholding a modern poison pill that was triggered by a potential acquirer/hostile bidder. The court’s opinion includes a number of important points for companies, including the following...

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Business Organization Updates, Mergers & Acquisitions Updates, Securities Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Wilson Sonsini Goodrich & Rosati | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »